Understanding Good Manufacturing Practice and how Biological Industries can support cell therapy development
Content matching 'cell therapy approval'
Scientists expect to have readouts next year from cell and gene therapy trials that could show that regenerative medicine is finally gaining traction.
Logical process designs for stem cell manufacturing: computational support tools for improved cost-effectiveness
Cell therapy weekly: FDA aims to advance gene therapies and T cells reprogrammed without the use of viral vectors
Cell therapy weekly: FDA issues strong warning, diabetes gene therapy shows promise in mice, the Cell and Gene Therapy Catapult unveils new project and Takeda eyes an acquisition
Latest developments compiled from 01 – 31 January 2015
Cell therapy weekly: UltraCAR-T given boost in fight against acute myeloid leukemia
Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial
FDA commissioner issues statement on new policies to ensure proper oversight of stem cell therapies
Cell therapy weekly: Is stem cell transplant survival associated with procedure performance number?
Chronic Achilles tendinosis affects both physically active and inactive individuals accounting for 30 to 50% of all sports injuries and 50% of occupation-related disorders in the United States. The study will include 28 participants with chronic Achilles tendinosis. Study participants will receive ultrasound-guided injections of either RCT-01 or placebo (on a 3:1 treatment-to-placebo ratio) directly into areas of injury within the Achilles tendon. Participants’ overall health and tendinosis will be monitored over a six month period while they undergo post-treatment physiotherapy to help facilitate recovery from their Achilles tendinosis.